FDA Approves Saphris Tablets (asenapine) To Treat Schizophrenia And Bipolar Disorder
Submitted by MedicalReplies on Sunday, 16 August 2009No Comment
The U.S. Food and Drug Administration has approved Saphris tablets (asenapine) to treat adults with schizophrenia, a chronic, severe and disabling brain disorder, and to treat bipolar I disorder in adults, a serious psychiatric disorder that causes shifts in a person’s mood, energy, and ability to function.
See the original post:
FDA Approves Saphris Tablets (asenapine) To Treat Schizophrenia And Bipolar Disorder
Leave your response!